Drug Trial Radar · NCT02105012
Study to Assess the Efficacy and Safety of Budesonide (PT008) in Adult Subjects With Mild to Moderate Persistent Asthma
Last checked: Nov 19, 2026Latest source record: Jun 6, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
147
Actual
Start
Apr 1, 2014
Primary completion
Sep 1, 2015
Study completion Sep 4, 2015
Sponsor
- Lead sponsor
- Pearl Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Apr 7, 2014
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Study to assess the efficacy and safety of four doses of budesonide inhalation aerosol (BD MDI, PT008) relative to placebo MDI in adult subjects with mild to moderate persistent asthma.
Conditions
- Asthma
Interventions
BD MDI 320 µgDrug
Budesonide Inhalation Aerosol administered as 2 inhalations BID
BD MDI 160 µgDrug
Budesonide Inhalation Aerosol administered as 2 inhalations BID
BD MDI 80 µgDrug
Budesonide Inhalation Aerosol administered as 2 inhalations BID
BD MDI 40 µgDrug
Budesonide Inhalation Aerosol administered as 2 inhalations BID
Placebo MDIDrug
Placebo MDI administered as 2 inhalations BID
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Morning Pre-dose Trough Forced Expiratory Volume in 1 Second (FEV1) at the End of the Treatment PeriodTime frame: Baseline to End of Treatment Period (Day 29 or Day 15 if Day 29 is missing)
Locations
41 sites in 1 country. Site status is shown where the registry gives one.
Pearl Therapeutics Study Site
Athens, Alabama
Pearl Therapeutics Study Site
Birmingham, Alabama
Pearl Therapeutics Study Site
Foley, Alabama
Pearl Therapeutics Study Site
Los Angeles, California
Pearl Therapeutics
Los Angeles, California
Pearl Therapeutics Study Site
Rolling Hills Estates, California
Pearl Therapeutics Study Site
San Diego, California
Pearl Therapeutics Study Site
Stockton, California
Pearl Therapeutics Study Site
Clearwater, Florida
Pearl Therapeutics Study Site
Clermont, Florida
Pearl Therapeutics Study Site
Miami, Florida
Pearl Therapeutics Study Site
Orlando, Florida
Pearl Therapeutics Study Site
Ormond Beach, Florida
Pearl Therapeutics Study Site
Saint Cloud, Florida
Pearl Therapeutics Study Site
Sebring, Florida
Pearl Therapeutics Study Site
Tampa, Florida
Pearl Therapeutics Study Site
Blue Island, Illinois
Pearl Therapeutics Study Site
North Dartmouth, Massachusetts
Pearl Therapeutics Study Site
Hazelwood, Missouri
Pearl Therapeutics Study Site
Skillman, New Jersey
Pearl Therapeutics Study Site
Charlotte, North Carolina
Pearl Therapeutics Study Site
Winston-Salem, North Carolina
Pearl Therapeutics Study Site
Cincinnati, Ohio
Pearl Therapeutics Study Site
Columbus, Ohio
Pearl Therapeutics Study Site
Dayton, Ohio
Pearl Therapeutics Study Site
Middleburg Heights, Ohio
Pearl Therapeutics Study Site
Oregon, Ohio
Pearl Therapeutics Study Site
Sylvania, Ohio
Pearl Therapeutics Study Site
Toledo, Ohio
Pearl Therapeutics Study Site
Oklahoma City, Oklahoma
Pearl Therapeutics Study Site
Lake Oswego, Oregon
Pearl Therapeutics Study Site
Medford, Oregon
Pearl Therapeutics Study Site
Greenville, South Carolina
Pearl Therapeutics Study Site
Spartanburg, South Carolina
Pearl Therapeutics Study Site
Rapid City, South Dakota
Pearl Therapeutics Study Site
Tullahoma, Tennessee
Pearl Therapeutics Study Site
El Paso, Texas
Pearl Therapeutics Study Site
Houston, Texas
Pearl Therapeutics Study Site
Plano, Texas
Pearl Therapeutics Study Site
San Antonio, Texas
Showing 40 of 41 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.